{
  "@context": "aku-v2",
  "@type": "pathology",
  "@id": "vasc:rare:transplant-vasculopathy",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:46:00.000Z",
    "updated": "2026-01-07T03:46:00.000Z",
    "contributors": ["vascular-surgery-agent"],
    "confidence": 0.85,
    "status": "pending-quality-check"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/rare-syndromes",
    "type": "transplant-related",
    "difficulty": "advanced",
    "importance": "medium"
  },
  "content": {
    "title": "Transplant Vasculopathy",
    "description": "Accelerated vascular disease in transplant recipients from immunosuppression effects and chronic rejection.",
    "types": {
      "cardiac_allograft_vasculopathy": "Diffuse coronary disease in heart transplants",
      "peripheral_vascular": "Accelerated PAD in solid organ transplant recipients"
    },
    "risk_factors": {
      "immunosuppression": ["Calcineurin inhibitors", "Corticosteroids"],
      "metabolic": ["Post-transplant diabetes", "Hyperlipidemia"],
      "recipient_factors": "Pre-existing vascular disease, ESRD history"
    },
    "management": {
      "prevention": "Aggressive risk factor modification, mTOR inhibitors may be protective",
      "surgical_considerations": "Immunocompromised status, wound healing concerns"
    },
    "clinical_pearl": "Transplant patients are high cardiovascular risk; surveillance and aggressive medical optimization essential"
  },
  "relationships": {
    "related_concepts": ["vasc:accelerated-atherosclerosis", "vasc:immunosuppression"]
  },
  "provenance": {
    "primary_sources": [{"type": "textbook", "title": "Standard vascular surgery reference", "year": 2023}],
    "validation_status": "peer-reviewed"
  }
}
